SCHEMBL276393

SCHEMBL276393

Brc1c2ccccc2c(-c2ccc(-c3ccccc3)cc2)c2cc(-c3ccccc3)ccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
MAPK1 P28482 2/20 0.41
KDM4E B2RXH2 2/20 0.41
MAPT P10636 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
GRIN2D O15399 1/20 0.41
GRIN2A Q12879 1/20 0.41
GRIN2B Q13224 1/20 0.41
GRIN2C Q14957 1/20 0.41
ESR1 P03372 3/20 0.40
ESR2 Q92731 3/20 0.40
ACHE P22303 2/20 0.37
ALOX5 P09917 1/20 0.36
JAK2 O60674 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
HSD17B1 P14061 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19283273 1.00 ALDH1A1 (0.41) ALDH1A1MAPK1KDM4EMAPTTDP1
SCHEMBL25625159 1.00 ALDH1A1 (0.41) ALDH1A1MAPK1KDM4EMAPTTDP1
SCHEMBL21517233 0.96 ALDH1A1 (0.41) ALDH1A1MAPK1KDM4EMAPTTDP1
SCHEMBL30307751 0.96 ALDH1A1 (0.41) ALDH1A1MAPK1KDM4EMAPTTDP1
SCHEMBL26086587 0.96 ALDH1A1 (0.41) ALDH1A1MAPK1KDM4EMAPTTDP1
SCHEMBL17125452 0.96 ALDH1A1 (0.41) ALDH1A1MAPK1KDM4EMAPTTDP1
SCHEMBL17366608 0.92 ALDH1A1 (0.41) ALDH1A1MAPK1KDM4EMAPTTDP1
SCHEMBL26384351 0.90 ALDH1A1 (0.43) ALDH1A1MAPK1KDM4EMAPTTDP1
SCHEMBL16455821 0.90 MKNK1 (0.48) MAPK1KDM4EMAPTTDP1L3MBTL1
SCHEMBL5599347 0.90 ESR2 (0.46) ALDH1A1MAPK1KDM4EMAPTESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110128329-B Nitrogen-containing heterocyclic arylamine derivative, application thereof and organic electroluminescent device 北京鼎材科技有限公司 2024-03-19 CN disclosed
US-20220384734-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-01 US disclosed
WO-2021033728-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE 出光興産株式会社 2021-02-25 WO disclosed
WO-2021033728-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE 出光興産株式会社 2021-02-25 WO disclosed
US-20150380655-A1 ANTHRACENE DERIVATIVE, METHOD FOR PREPARING THE SAME, USE THEREOF AND ORGANIC LIGHT EMITTING DEVICE BOE TECHNOLOGY GROUP CO., LTD. (CN) 2015-12-31 US disclosed
US-20150380655-A1 ANTHRACENE DERIVATIVE, METHOD FOR PREPARING THE SAME, USE THEREOF AND ORGANIC LIGHT EMITTING DEVICE BOE TECHNOLOGY GROUP CO., LTD. (CN) 2015-12-31 US disclosed
US-8134035-B2 Preparation of asymmetric anthracene derivatives and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2012-03-13 US disclosed
US-8134035-B2 Preparation of asymmetric anthracene derivatives and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2012-03-13 US disclosed
US-20110065924-A1 PREPARATION OF ASYMMETRIC ANTHRACENE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME DOOSAN CORPORATION (KR) 2011-03-17 US disclosed
US-20110065924-A1 PREPARATION OF ASYMMETRIC ANTHRACENE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME DOOSAN CORPORATION (KR) 2011-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065924-A1 PREPARATION OF ASYMMETRIC ANTHRACENE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME AKR7A2, ACMSD, ALKBH3 ALDH1A1 1554/4885MAPK1 3650/4885KDM4E 2577/4885
US-20220384734-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE MCOLN2, RER1, L1CAM ALDH1A1 1016/4885MAPK1 959/4885KDM4E 3141/4885
US-20150380655-A1 ANTHRACENE DERIVATIVE, METHOD FOR PREPARING THE SAME, USE THEREOF AND ORGANIC LIGHT EMITTING DEVICE ALAD, PPOX, CYBA ALDH1A1 46/4885MAPK1 4103/4885KDM4E 2790/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.